A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

NCT04617314 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: RC108

Sponsor

RemeGen Co., Ltd.